 |
GW Pharmaceuticals
Last updated: October 10, 2024
Justin Gover, CEO
UK | Funding: $1.2B (+)
Website: https://www.gwpharm.com
GW has established a world leading position in the development of plant-derived cannabinoid therapeutics through its proven drug discovery and development processes, intellectual property portfolio and regulatory and manufacturing expertise.
Website: https://www.gwpharm.com
GW has established a world leading position in the development of plant-derived cannabinoid therapeutics through its proven drug discovery and development processes, intellectual property portfolio and regulatory and manufacturing expertise.
